KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Q4 2025 value amounting to 0.43.

  • Teva Pharmaceutical Industries' Asset Utilization Ratio rose 493.7% to 0.43 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.43, marking a year-over-year increase of 493.7%. This contributed to the annual value of 0.43 for FY2025, which is 787.36% up from last year.
  • As of Q4 2025, Teva Pharmaceutical Industries' Asset Utilization Ratio stood at 0.43, which was up 493.7% from 0.42 recorded in Q3 2025.
  • In the past 5 years, Teva Pharmaceutical Industries' Asset Utilization Ratio registered a high of 0.43 during Q4 2025, and its lowest value of 0.33 during Q1 2021.
  • For the 5-year period, Teva Pharmaceutical Industries' Asset Utilization Ratio averaged around 0.37, with its median value being 0.35 (2023).
  • As far as peak fluctuations go, Teva Pharmaceutical Industries' Asset Utilization Ratio decreased by 15.69% in 2022, and later skyrocketed by 1519.06% in 2025.
  • Over the past 5 years, Teva Pharmaceutical Industries' Asset Utilization Ratio (Quarter) stood at 0.33 in 2021, then increased by 1.72% to 0.34 in 2022, then grew by 9.5% to 0.37 in 2023, then increased by 10.19% to 0.41 in 2024, then increased by 4.94% to 0.43 in 2025.
  • Its Asset Utilization Ratio was 0.43 in Q4 2025, compared to 0.42 in Q3 2025 and 0.42 in Q2 2025.